Retrospective study of the efficacy and safety of docetaxel/carboplatin combination therapy as postoperative adjuvant chemotherapy for nonsquamous cell carcinoma of the cervix.

Ryo Koike Mayu Yunokawa Kohei Omatsu Nozomi Kurihara Hidetaka Nomura Hiroyuki Kanao Akihiko Sekizawa

Published in: International journal of clinical oncology (2023)

DC therapy at our institution showed good 2 year RFS, and postoperative adjuvant therapy with DC therapy is suggested as a useful strategy for patients with nonsquamous cervical carcinoma.

Keyphrases

combination therapy
patients undergoing
dendritic cells
clinical trial
randomized controlled trial
stem cells
squamous cell carcinoma
immune response
phase ii study
mesenchymal stem cells
bone marrow
open label